June 25, 2020
R-1000, a cuvette that can process up to 1 mL (or up to 200 million) cells, is first new product offering Enhanced range of volumes and design features will support expanded use in both cell therapy drug development and early drug discovery Gaithersburg, MD: MaxCyte, the global clinical-stage cell-based medicines and life sciences company, announced [...]
HALO LABS LAUNCHES AURA FOR PARTICLE AND AGGREGATE ID IN BIOTHERAPEUTIC DEVELOPMENT – PR NEWSWIRE
June 25, 2020
Aura revolutionizes biologic stability analysis, enabling simple protein and non-protein aggregate identification in formulation development and analytical testing BURLINGAME, CA – Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest aggregate and particle identification system, called Aura™. Aura is the next generation of the Horizon®, Halo [...]
June 25, 2020
More than 305,000 high-resolution, multi-channel COVID-19 cellular images captured in less than four weeks with Molecular Devices ImageXpress® Micro Confocal High-Content Imaging System are now available to the scientific community. SAN JOSE, Calif. – With the COVID-19 pandemic impacting millions around the globe, researchers are racing to develop a vaccine or drug treatment. In an effort to [...]
Genedata Aids Merus in Development of Precision Immunotherapies
June 25, 2020
Genedata provides its scalable data management and analysis platform, Genedata Profiler, as managed SaaS for translational and clinical research Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that it has entered into a multi-year contract with Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies [...]
IDT offers powerful new NGS tools for COVID-19 research
June 25, 2020
Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, has developed new Next Generation Sequencing (NGS) tools to assist researchers in tracking and understanding the spread of COVID-19. The Company is also establishing partnerships to increase access to NGS [...]
Zebra Analytix Awarded NIH Funding to Improve Workplace Safety
June 24, 2020
This funding will be used to develop a compact, low-cost device for the autonomous monitoring of hazardous substances in high-risk settings, such as oil refining, power generation, and chemical manufacturing. FAYETTEVILLE, Ark. Zebra Analytix—a VIC Technology Venture Development portfolio company—announced today that it has received a Small Business Innovation Research (SBIR) grant from the National [...]
June 24, 2020
Cytiva’s Fast Trak biomanufacturing services advances pre-clinical through Phase II development and manufacturing CDMO facility offers cutting-edge automation capabilities and flexible solutions for biotechnology companies Cytiva, formerly part of GE Healthcare Life Sciences, is celebrating the completion of an extensive renovation to its Fast Trak cGMP contract biomanufacturing and process development site in Marlborough, Massachusetts, [...]
June 24, 2020
iGLS Among Labs Chosen by Spanish Health Authorities to Expand SARS-CoV-2 Screening End-to-End Workflow from Extraction through Real-Time PCR Using Fluidigm Microfluidics Technology and Reagents Screening of Critical Populations Under Way, Capacity of Up to 6,000 Tests Per Day on Single Instrument SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with [...]
June 24, 2020
DURHAM, N.C. -- Phitonex, Inc., developers of next generation fluorescent reagents for single cell analysis, launched more new fluorescent labels at one time than have been released in the past 2 decades. Today, they also revealed a suite of fluorescent labels for a third laser line (NovaRed), introduced the first digital fluorescent labels, and are [...]
Certara Launches Version 8.3 of Phoenix™ Biosimulation Software for Drug Development
June 24, 2020
Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, NJ – Certara®, the global leader in biosimulation, today announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software Version 8.3 delivers new features to drive efficiencies and quality and [...]

